| JO3598B1              (en) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | Boronic acids and esters as inhibitors of fatty acid amide hydrolase | 
| WO2008043791A2              (en)* | 2006-10-13 | 2008-04-17 | Smithkline Beecham Corporation | Thiophene derivatives for treating hepatitis c | 
| US7964580B2              (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs | 
| AU2008248116A1              (en) | 2007-05-04 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Combination therapy for the treatment of HCV infection | 
| AR072249A1              (en) | 2008-04-09 | 2010-08-18 | Infinity Pharmaceuticals Inc | INHIBITORS OF AMIDA HYDROLASS ACID FAT. APPLICATIONS. METHODS | 
| US8173621B2              (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates | 
| KR101529062B1              (en)* | 2008-09-05 | 2015-06-16 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same | 
| NZ617066A              (en) | 2008-12-23 | 2015-02-27 | Gilead Pharmasset Llc | Nucleoside analogs | 
| PA8855601A1              (en) | 2008-12-23 | 2010-07-27 |  | NUCLEOSID FORFORMIDATES | 
| WO2010075554A1              (en) | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Synthesis of purine nucleosides | 
| WO2010118155A1              (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase | 
| WO2010118159A1              (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase | 
| TWI583692B              (en) | 2009-05-20 | 2017-05-21 | 基利法瑪席特有限責任公司 | Nucleoside phosphoramidates | 
| US8618076B2              (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates | 
| US8993604B2              (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections | 
| MX336687B              (en)* | 2009-06-30 | 2016-01-28 | Siga Technologies Inc | Treatment and prevention of dengue virus infections. | 
| SG182475A1              (en) | 2010-01-15 | 2012-08-30 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses | 
| CA2788587C              (en) | 2010-02-03 | 2020-03-10 | Infinity Pharmaceuticals, Inc. | Fatty acid amide hydrolase inhibitors | 
| UY33312A              (en) | 2010-03-31 | 2011-10-31 | Pharmasset Inc | PURINE NUCLEOSIDE PHOSPHORAMIDATE | 
| CL2011000718A1              (en) | 2010-03-31 | 2012-04-09 | Gilead Pharmasset Llc | Process for the preparation of enantiomeric phosphorus compounds. | 
| US8563530B2              (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate | 
| WO2012075140A1              (en) | 2010-11-30 | 2012-06-07 | Pharmasset, Inc. | Compounds | 
| US8889159B2              (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus | 
| SG11201600919UA              (en) | 2013-08-27 | 2016-03-30 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds | 
| CN110143940B              (en)* | 2019-05-07 | 2022-12-30 | 中国科学技术大学 | Method for preparing 2, 5-furan diformyl chloride from 2, 5-furan diformyl aldehyde |